Aug 11 (Reuters) - Shire Plc SHP.L
* Shire Pharma Canada says its Onivyde has received approval in Canada for treatment of Metastatic Adenocarcinoma of Pancreas in Post-Gemcitabine setting
* Shire Pharma Canada says Onivyde approved in combination with 5-Fluorouracil and Leucovorin